Entry price: 106.83
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 678%
- EPS % Chg (Previous Qtr): -11.64%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 8053%
- Sales % Chg (Previous Qtr): 63%
- 3-Year Sales Growth Rate: 91%
- Annual Pre -Tax Margin: -522.8%
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 678%
- EPS % Chg (Previous Qtr): -11.64%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 8053%
- Sales % Chg (Previous Qtr): 63%
- 3-Year Sales Growth Rate: 91%
- Annual Pre -Tax Margin: -522.8%
Komentarz:
Sold at 90.47
Return: -15.31%
Return: -15.31%
Komentarz:
- EPS % Chg (Last Qtr): -13%
- Sales % Chg (Last Qtr): -34%